Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
暂无分享,去创建一个
[1] Robert L. Swain,et al. National Association of Boards of Pharmacy , 1954 .
[2] E. Lorenz. Deterministic nonperiodic flow , 1963 .
[3] W. Odum,et al. Environmental Degradation and the Tyranny of Small Decisions , 1982 .
[4] David Friedman,et al. The Resource Conservation and Recovery Act , 1984 .
[5] C. S. Holling. Resilience of ecosystems: local surprise and global change. , 1985 .
[6] Carl Rogers,et al. AIDS Among Drug Users in Europe: Second Review. Copenhagen: WHO Regional Office For Europe. , 1994, British Journal of Psychiatry.
[7] Gene Bazan. Our Ecological Footprint: Reducing Human Impact on the Earth , 1997 .
[8] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[9] C. A. Smith. RATIONALE FOR INCLUSION OF CRITERIA FOR PROPER DISPOSAL OF MONOGRAPH PHARMACEUTICAL PREPARATIONS BASED ON THE RESOURCE CONSERVATION AND RECOVERY ACT , 1999 .
[10] J. Stoker,et al. The Department of Health and Human Services. , 1999, Home healthcare nurse.
[11] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[12] Tamar Terzian. Direct-to-Consumer Prescription Drug Advertising , 1999, American Journal of Law & Medicine.
[13] Organización Mundial de la Salud. Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies , 1999 .
[14] Canary Wharf,et al. The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use , 2000 .
[15] L. Greene. Controversy swirls around toilet-to-tap project. , 2000, Environmental health perspectives.
[16] J. Muñoz-Bellido,et al. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. , 2000, International journal of antimicrobial agents.
[17] U. Epa,et al. Office of Pollution Prevention and Toxics , 2000 .
[18] D. Handley,et al. Dose-Response Evaluation of Levalbuterol Versus Racemic Albuterol in Patients with Asthma , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.
[19] J. Thornton,et al. Beyond Risk: An Ecological Paradigm to Prevent Global Chemical Pollution , 2000, International journal of occupational and environmental health.
[20] Carola Hanisch,et al. Is extended producer responsibility effective? , 2000, Environmental science & technology.
[21] G. Cappiello,et al. Hygienic aspects related to burial , 2000 .
[22] L L Needham,et al. Levels of seven urinary phthalate metabolites in a human reference population. , 2000, Environmental health perspectives.
[23] R. Arole. Community based health and development: the Jamkhed experience , 2001 .
[24] Alastair Baker,et al. Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.
[25] Leon Mann,et al. The Innovation Imperative , 2001 .
[26] Christian G. Daughton,et al. Pharmaceuticals and personal care products in the environment , 2001 .
[27] J. Farman,et al. Late lessons from early warnings: the precautionary principle 1896-2000 , 2002 .
[28] G. Reid,et al. Can bacterial interference prevent infection? , 2001, Trends in microbiology.
[29] Christian G. Daughton,et al. Illicit Drugs in Municipal Sewage: Proposed New Nonintrusive Tool to Heighten Public Awareness of Societal Use of Illicit-Abused Drugs and Their Potential for Ecological Consequences , 2001 .
[30] P Slovic,et al. The risk game. , 2001, Journal of hazardous materials.
[31] E. Oren,et al. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. , 2001, JAMA.
[32] K. Shen,et al. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia , 2001, Brain Research.
[33] Christian G. Daughton. Literature Forensics? Door to What Was Known but Now Forgotten☆☆☆ , 2001 .
[34] L. Goldman,et al. Technical report: mercury in the environment: implications for pediatricians. , 2001, Pediatrics.
[35] J. Drewes,et al. Concerns about Pharmaceuticals in Water Reuse, Groundwater Recharge, and Animal Waste , 2001 .
[36] R. Velagaleti,et al. Regulatory Oversight for the Environmental Assessment of Human and Animal Health Drugs: Environmental Assessment Regulations for Drugs , 2001 .
[37] D. Epel,et al. Multidrug-Multixenobiotic Transporters and Their Significance with Respect to Environmental Levels of Pharmaceuticals and Personal Care Products , 2001 .
[38] Juan R. Granja,et al. Antibacterial agents based on the cyclic d,l-α-peptide architecture , 2001, Nature.
[39] P. Fong. Antidepressants in Aquatic Organisms: A Wide Range of Effects , 2001 .
[40] Christian G. Daughton,et al. Pharmaceuticals and Care Products in the Environment: Scientific and Regulatory Issues , 2001 .
[41] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[42] D. Christensen. Medicinal mimicry: Sometimes, placebos work—but how? , 2001 .
[43] M Maurer,et al. Re-engineering the toilet for sustainable waste water management. , 2001, Environmental science & technology.
[44] null null,et al. 2001 Report Card for America's Infrastructure , 2001 .
[45] Michael Berry,et al. Office of National Drug Control Policy , 2002 .
[46] B. Levin,et al. Antibiotics in agriculture: When is it time to close the barn door? , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Leuchter,et al. Changes in brain function of depressed subjects during treatment with placebo. , 2002, The American journal of psychiatry.
[48] Stu Borman. In situ click chemistry , 2002 .
[49] Paula Rochon,et al. Improving the quality of medication use in elderly patients: a not-so-simple prescription. , 2002, Archives of internal medicine.
[50] Hiroaki Suga,et al. A tRNA aminoacylation system for non-natural amino acids based on a programmable ribozyme , 2002, Nature Biotechnology.
[51] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[52] Frcp,et al. Azithromycin for Acute Bronchitis , 2002 .
[53] N. Kerse,et al. Do delayed prescriptions reduce the use of antibiotics for the common cold? A single-blind controlled trial. , 2002, The Journal of family practice.
[54] P. Maurette,et al. [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.
[55] Hans Söderlund,et al. Antibody-Based Bio-Nanotube Membranes for Enantiomeric Drug Separations , 2002, Science.
[56] R. Velagaleti,et al. Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal. , 2002, Environmental health perspectives.
[57] D. Rapport. The Health of Ecology and the Ecology of Health , 2002 .
[58] M. DiCarlo,et al. How should a fever mercury thermometer be disposed of ? A survey of those likely to be asked. , 2002, Pediatrics.
[59] Roman Frigg,et al. Ubiquity. The Science of History ... Or Why The World is Simpler Than We Think , 2002 .
[60] William McDonough,et al. Cradle to Cradle: Remaking the Way We Make Things , 2002 .
[61] R. Renner. Do cattle growth hormones pose an environmental risk? , 2002, Environmental science & technology.
[62] Disciplinary Committee,et al. Royal Pharmaceutical Society of Great Britain , 2002 .
[63] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[64] T. Heberer. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.
[65] Joy Melnikow,et al. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. , 2002, JAMA.
[66] E. Berndt,et al. Promotion of prescription drugs to consumers. , 2002, The New England journal of medicine.
[67] B. Beale. Probiotics: Their tiny worlds are under scrutiny , 2002 .
[68] D. Dietrich,et al. Hot spot pollutants: pharmaceuticals in the environment. , 2004, Toxicology letters.
[69] K. Chopra,et al. Probiotics: potential pharmaceutical applications. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[70] Stu Borman. IN SITU CLICK CHEMISTRY: Templating strategy offers potential route to new drugs and other functional compounds , 2002 .
[71] J. Straub. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. , 2002, Toxicology letters.
[72] Terri Damstra,et al. Global assessment of the state-of-the-science of endocrine disruptors , 2002 .
[73] J. Alper. Breaching the Membrane , 2002, Science.
[74] M. I C H A E,et al. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance , 2002 .
[75] R Otterpohl,et al. Options for alternative types of sewerage and treatment systems directed to improvement of the overall performance. , 2002, Water science and technology : a journal of the International Association on Water Pollution Research.
[76] Jean Gayton Carroll,et al. Crossing the Quality Chasm: A New Health System for the 21st Century , 2002 .
[77] A. Evans,et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial , 2002, The Lancet.
[78] B. Harder. Germs that do a body good: Bacteria might someday keep the doctor away , 2002 .
[79] J. Emanuel,et al. Breaking down the barriers , 2002, Nature.
[80] P. Kay,et al. Review of Veterinary Medicines in the Environment , 2002 .
[81] M. Magnani,et al. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides , 2002, Gene Therapy.
[82] N. Greenspan. Not-so-intelligent design , 2002 .
[83] C. Daughton. Environmental stewardship and drugs as pollutants , 2002, The Lancet.
[84] B. Sanders,et al. Cross-shelf transport at Huntington Beach. Implications for the fate of sewage discharged through an offshore ocean outfall. , 2002, Environmental science & technology.
[85] Wayne G. Landis,et al. Uncertainty in the Extrapolation from Individual Effects to Impacts upon Landscapes , 2002 .
[86] T. Strandberg,et al. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. , 2002, Archives of internal medicine.
[87] Simon Webb,et al. Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER. , 2002, Toxicology letters.
[88] David L. Smith,et al. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[89] C. Daughton. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. , 2002, Environmental health perspectives.
[90] E. Dooley. National Council for Science and the Environment. (Forum) , 2003 .
[91] Effects. Oil in the Sea III: Inputs, Fates, and Effects , 2003 .
[92] H. Blutstein. A forgotten pioneer of sustainability , 2003 .
[93] Christine M. Coussens,et al. Environmental health indicators : bridging the chasm of public health and the environment : workshop summary , 2004 .
[94] Westone,et al. Home Page , 2004, 2022 2nd International Conference on Intelligent Cybernetics Technology & Applications (ICICyTA).
[95] David Gee,et al. LATE LESSONS FROM EARLY WARNINGS , 2004 .
[96] J. Weissman,et al. Promoting Appropriate Antibiotic Use in the Community , 2005 .